DBV Technologies (DBVT) Change in Receivables (2020 - 2021)

DBV Technologies (DBVT) reported Change in Receivables of $24000.0 for Q4 2021, down 75.0% year-over-year from $96000.0 in Q4 2020, and up 2300.0% quarter-over-quarter from $1000.0 in Q3 2021.

DBV Technologies (DBVT) Change in Receivables (2020 - 2021) Analysis & Trends

DBV Technologies (DBVT) has 2 years of Change in Receivables data on file, last reported at $24000.0 in Q4 2021.

  • Change in Receivables for Q4 2021 came in at $24000.0, down 75.0% year-over-year; the trailing twelve-month figure through Sep 2022 was $24000.0 (up 101.15% YoY), and the FY2021 annual result was -$2.2 million, down 203.86% from the prior year.
  • Change in Receivables climbed to $24000.0 in Q4 2021 per DBVT's latest filing, from $1000.0 in the prior quarter.
  • Over five years, Change in Receivables peaked at $2.0 million in Q3 2020 and troughed at -$2.1 million in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 22,529.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -39.80 Mn
9 Abivax 91.96 Bn 91.96 Bn - -4.08 Mn
10 DBV Technologies 6.63 Bn 6.41 Bn -3.90 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2021 24,000.00
Dec 31, 2021 24,000.00
Sep 30, 2021 1,000.00
Sep 30, 2021 1,000.00
Jun 30, 2021 -74,000.00
Jun 30, 2021 -74,000.00
Mar 31, 2021 -2.10 Mn
Mar 31, 2021 -2.10 Mn
Dec 31, 2020 96,000.00
Dec 31, 2020 96,000.00
Sep 30, 2020 1.98 Mn
Sep 30, 2020 1.98 Mn